Neuroendocrine Prostate Cancer
📧 Sign up to get email alerts when something new happens for Neuroendocrine Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: A Study of AMG 757 in Participants With Neuroendocrine Prostate Cancer [Phase 1]
This Phase 1 study evaluates AMG 757 in neuroendocrine prostate cancer and has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-08-24Clinical Trial Update: A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours [Phase 1]
A Phase 1 study of [225Ac]-FPI-2059 in adults with solid tumours was terminated.
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate [Phase 1]
Phase 1 trial evaluating pembrolizumab with chemotherapy for locally advanced or metastatic small cell and neuroendocrine cancers of the uro…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for rovalpituzumab tesirine in DL3-expressing advanced solid tumors shows termination with results posted.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: A Phase II Trial of MLN8237 in Patients With Metastatic Castrate Resistant and Neuroendocrine Prostate Cancer [Phase 2]
Phase II trial of MLN8237 in metastatic castration-resistant and neuroendocrine prostate cancer completed; results posted in 2017.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.